InvestorsHub Logo
Followers 1
Posts 73
Boards Moderated 0
Alias Born 05/09/2011

Re: leifsmith post# 33214

Monday, 07/25/2011 9:31:53 AM

Monday, July 25, 2011 9:31:53 AM

Post# of 92948
Blastomere Program
ACT’s single-cell blastomere technology (“blastomere technique”) is a patented, proprietary method for generating human embryonic stem cells (hESCs) without damage to the embryo, thus directly addressing the issue that has made embryonic stem cell research a controversial topic in some quarters. Documented in scientific journals Nature, Cell Stem Cell and elsewhere, the technique uses a single-cell biopsy approach to generate hESCs.

The technique involves removal of a single blastomere (cell) from an eight-cell stage embryo, which can then generate stem cell lines that have the same characteristics as the embryo. The biopsy procedure does not damage or destroy the embryo, nor does it interfere with the embryo’s developmental potential. In fact, the technique is very similar to pre-implantation genetic diagnosis (PGD). PGD is widely used during in vitro fertilization (IVF), and its safety and efficacy are amply demonstrated by the thousands of healthy people worldwide whose parents used PGD.

ACT’s single-blastomere technique is a viable alternative to other techniques that derive hESCs from the inner cell mass of later-stage embryos, thus destroying their potential for further development and raising ethical objections from various parties.

This was obtained from advancedcell.com

This is probably were your dd should begin ,, it's really not that difficult to find.. The truth is out there ... This is not my opinion nor the opinion of others on this board .. this is now scientific fact that has been proven effective without causing damaged to embryos by Dr Lanza and his team
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.